Search

Geron Corp

Suletud

SektorTervishoid

1.25 1.63

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.22

Max

1.31

Põhinäitajad

By Trading Economics

Sissetulek

-13M

-17M

Müük

5.6M

57M

Aktsiakasum

-0.02

Kasumimarginaal

-29.019

Töötajad

258

EBITDA

-16M

-12M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+230.79% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

4. nov 2026

Turustatistika

By TradingEconomics

Turukapital

14M

835M

Eelmine avamishind

-0.38

Eelmine sulgemishind

1.25

Uudiste sentiment

By Acuity

81%

19%

305 / 339 Pingereas Healthcare

Geron Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. sept 2026, 22:50 UTC

Geron Corp is advancing in after-market trading, recovering from earlier declines, though it remains below its 20-day moving average.

18. sept 2026, 19:36 UTC

Geron Corp shares fell sharply, continuing a decline since Thursday and trading significantly below the 20-day moving average.

17. sept 2026, 23:01 UTC

Geron Corp's shares rose in after-market trading, recovering from earlier losses to reach their highest level of the day since Thursday's close.

16. sept 2026, 20:10 UTC

Geron Corp's shares fell sharply, continuing a decline from Tuesday and trading near the lower end of its one-month range.

15. sept 2026, 23:11 UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Tuesday's close and about 11.99% below the 20-day moving average.

10. sept 2026, 20:06 UTC

Geron Corp shares are lower today, continuing a trend of four consecutive sessions of declines amid a broader market downturn.

9. sept 2026, 20:01 UTC

Geron Corp's shares are trading lower amid broader market declines, nearing the bottom of their one-month range and below the 20-day moving average.

8. sept 2026, 20:07 UTC

Geron Corp's shares are lower today, continuing a downward trend since Friday amid broader market pressure linked to interest rate hike speculation.

3. sept 2026, 20:07 UTC

Geron Corp's shares are lower during Thursday's session amid broader market declines, with no specific company news identified to explain the movement.

2. sept 2026, 23:06 UTC

Geron Corp shares declined in after-market trading, despite remaining above their 20-day moving average and near the upper end of their one-month trading range.

1. sept 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting a positive move since Tuesday's close amid broader market fluctuations. No specific news was identified.

31. aug 2026, 23:01 UTC

Geron Corp shares are higher in after-market trading, following notable volatility. The stock's movement contrasts with recent lower closes over the past four sessions.

28. aug 2026, 19:46 UTC

Geron Corp shares are lower today, continuing a three-day decline amid ongoing inflation concerns and recent comments from Fed officials on price stability.

27. aug 2026, 23:01 UTC

Geron Corp traded roughly flat in after-market hours, remaining effectively unchanged since Thursday's close, with stability indicated by its position above the 20-day moving average.

26. aug 2026, 19:56 UTC

Geron Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains above its 20-day moving average.

25. aug 2026, 21:51 UTC

Geron Corp shares declined after market hours, reflecting broader trends amid a sharp drop in crude oil prices. The stock remains near its one-month range high.

24. aug 2026, 23:46 UTC

Geron Corp shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

21. aug 2026, 19:46 UTC

Geron Corp shares are lower today, reflecting broader market trends, despite remaining above the 20-day moving average and near the upper end of the one-month range.

20. aug 2026, 23:06 UTC

Geron Corp shares are lower in after-market hours, showing notable volatility while remaining above their 20-day moving average and near the month's upper range.

19. aug 2026, 19:26 UTC

Geron Corp shares are higher today, continuing a three-day upward trend. The stock remains above its 20-day moving average, indicating strong market positioning.

18. aug 2026, 21:03 UTC

News

Geron Corporation's shares are lower in after-market trading following the grant of stock options to new employees at an exercise price of $1.53.

17. aug 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting notable strength. The stock is significantly above its 20-day moving average.

14. aug 2026, 20:02 UTC

Macro Event

Geron Corp shares are lower today amid broader market declines and disappointing U.S. retail sales data, reflecting negative investor sentiment.

13. aug 2026, 23:36 UTC

Shares of Geron Corp are trading higher in after-market hours, reflecting a strong performance backdrop despite no specific news identified.

12. aug 2026, 23:36 UTC

Geron Corp shares are higher in after-market trading, reflecting an upward move since Wednesday's close. The stock remains above its 20-day moving average.

11. aug 2026, 22:52 UTC

Geron Corp shares are lower in after-market trading with no specific news identified. Broader market sentiment was pressured by rising crude oil prices.

10. aug 2026, 23:06 UTC

Geron Corp shares are higher in after-market hours, reflecting a gain despite mixed market sentiment and geopolitical tensions affecting global energy markets.

7. aug 2026, 20:03 UTC

Geron Corp shares are sharply lower during Friday's trading session, reflecting a broader market decline with no specific news identified to explain the movement.

6. aug 2026, 23:06 UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Thursday's close amid a strong recent performance backdrop.

5. aug 2026, 23:31 UTC

Geron Corp shares are lower in after-market hours, continuing a decline that began during regular trading, with no specific news identified.

Võrdlus sarnastega

Hinnamuutus

Geron Corp Prognoos

Hinnasiht

By TipRanks

230.79% tõus

12 kuu keskmine prognoos

Keskmine 4.333 USD  230.79%

Kõrge 6 USD

Madal 3 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Geron Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

3

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

305 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.